Resistance mechanisms to treatment with temozolomide in glioma cells
Exploring the role of NRF2 and circadian cycle as mediators of tumor resistance to...
Exploring the role of NRF2 as mediator of tumor resistance to chemotherapy
Exploring the role of NRF2-pathway in ferroptosis in cancer cells
Obtaining human glioblastoma NRF2 knockout via CRISPR / Cas9